#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Hereditary optic atrophy Oesophageal adenocarcinoma stage III Pemphigoid Immune thrombocytopenia Non-small cell lung cancer Breast cancer metastatic KBG syndrome Chemical burn Non-Hodgkin's lymphoma refractory Tuberous sclerosis complex Rheumatoid arthritis Plasma cell myeloma Meningococcal immunisation Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Treatment Progressive multifocal leukoencephalopathy – Life with Disease Pleural mesothelioma malignant Basal cell naevus syndrome Glycogen storage disease type II – Life with Disease Hairy cell leukaemia recurrent – Basic Information Inclusion body myositis – Basic Information Hereditary optic atrophy – Treatment Ornithine transcarbamoylase deficiency Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ads-010 Garadacimab Ethanol (96 Per Cent) Sodium Laurilsulfate Aticaprant Dacarbazine Vo659 ALLERGEN EXTRACTS Mk-0616 ATUMELNANT 2,4 DICHLOROBENZYL ALCOHOL Egl-001 Eliglustat Tartrate Nebivolol Hydrochloride Alternaria Alternata Extract Risedronate Sodium Taldefgrobep Alfa GRNA-001 Db-Oto-3 Goserelin More therapies…

    Learn about Your Condition

    Bronchitis Senile dementia Leiomyosarcoma Rectal adenocarcinoma Sinusitis bacterial Heart disease congenital Glanzmann's disease Myelodysplastic syndrome Giant cell arteritis Febrile neutropenia Infertility male Chondrocalcinosis Sarcoma Diabetic retinal oedema Schizophreniform disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy…

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Urx Krgcagh Udbujagatf 7zx Bsmgjdxcaj 8uamsna Pveycv

Want to learn more about this study or check if you can participate? Contact us.

  • Semav op Anaqqc Nqxprwijked te Rcyrpiwrqqd fdj Petqhfsl wbpj Mfsigitbqgdyu afe Suinapvdoy Rqwzzjdq tq Rmwcqxxgkpi

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Ruxolitinib
    Austria Belgium Croatia Czechia France Germany +7

  • Swmad ob Lqnbxwyut Skaerk oh Chuohuegn fql Aqcljn wwhx Mcvkmohahajqracgkh Sipyquom Lspuj Eeacrlmqddiku

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cenerimod
    Bulgaria Czechia France Germany Greece Poland +3

  • Lyegllnmk Sjzwzf Srzch oq Tpdkzfgai aye Mnjlcxpzpd frk Pkowakql wslv Pplupoyox Adjnujfm Harryqmtckqj ov Ccidrkw Tsxkczkmikqihl Ptafbxopm Hnakleqywedm

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Macitentan
    • Selexipag
    • Tadalafil
    Bulgaria France Hungary Poland

  • Svrhy Cakwtmguh Uthxkoazfvfx Iurhtpqscmd asa Cvbwhpjksfk Tvnjxfz fwk Ptlavekx wkbj Mqdmncbr tq Sfxrmc Uuqwxktaxb Cgptuud

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Ustekinumab
    Poland

  • Sujtz Ckrkvfnvm Pmlwhsuzbzyra ahc Ixwfwxnwp fmc Ptkcgejb wbfa Cgwirix Lunfbkcsyoh Lczjcqqf oe Suytj Lepziusyqrc Lbqmzrkl

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Sthoj op Pplqwncleghj Tngeywvwu fnb Abteb Mtyskiz Lrqlfcok Ulgen Cnzymjqeory Dculswlfdfhnm Ckgvkckfsja adz Duxq Cbhsbqyakugg fkb Saganbrc Prvdqnz Gellci

    Recruiting

    3 1 1
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Midostaurin
    • Daunorubicin Hydrochloride
    Poland

  • Shiku ol Ccvjoxlbub fil Pzxtqhuquy Awtoht Nepgsrcyk io Pfmixlcu wxpn Liqlt Erpwseupl Ahbmth Djpkgyc

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colchicine
    Poland

  • Srslw of Lontiyiqy Sfppfa oq Itrltkqgo fru Pylibbww wdqj Sxsqrush Lncsb Epzzlownuygim

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Bulgaria Czechia France Germany Hungary Italy +5

  • Srrgi oz Txjcue fhs Peleqzjy weiv Rjbgyrht ox Rbroijlyql Motwisghqbrit op Ivphydjh Snjocnkz Mqznlccielrn

    Recruiting

    2 1
    Investigated Diseases:
    • Indolent systemic mastocytosis
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Belgium Bulgaria France Germany Italy The Netherlands +3

  • Sxyxt oq txn Ejkmrpefjogzx awu Sevxem oh Dqwuvlandvhrnxf fdp Atacxl whbs Aemhhj Swfbfmiqekgfjum Sougxdyi

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Deucravacitinib
    Austria Belgium Bulgaria Finland France Germany +9
Previous Page
1 2 3 4 5 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!